Disclosure Panels Details Page
Breast Cancer Panel - Disclosures as of 03/29/2023
|
Panel Member
(Spouse/Domestic Partner/Dependent) |
Clinical Research Support/Data Safety Monitoring Board | Scientific Advisory Boards, Consultant, or Expert Witness | Promotional Advisory Boards, Consultant, or Speakers Bureau | Employment/ Governing Board, Patent, Equity, or Royalty | Date Completed |
|---|---|---|---|---|---|
| Jame Abraham MD,FACP | Daiichi- Sankyo Co. Pfizer Inc. Seattle Genetics, Inc. |
None | None | None | 12/11/2022 |
| Vandana Abramson MD | Eli Lilly and Company Immunomedics, Inc. Roche Laboratories, Inc. Seattle Genetics, Inc. Zentana |
Daiichi- Sankyo Co. Eisai Inc. MacroGenics Signatera |
None | None | 05/12/2022 |
| Rebecca Aft MD,PhD | None | None | None | None | 01/21/2023 |
| Doreen Agnese MD | None | None | None | None | 03/27/2023 |
| Kimberly Allison MD | None | Mammotome | None | None | 12/12/2022 |
| Bethany Anderson MD | Miscellaneous | None | None | None | 01/15/2023 |
| Marian Birkeland PhD | None | None | None | None | 12/12/2022 |
| Nicole Blankenhorn | None | None | None | None | 03/21/2023 |
| Harold Burstein PhD,MD | None | None | None | None | 11/18/2022 |
| Helen Chew MD | None | None | None | None | 03/04/2023 |
| Chau Dang MD | Daiichi- Sankyo Co. Genentech, Inc. Puma Biotechnology |
Daiichi- Sankyo Co. Novartis Pharmaceuticals Corporation Pfizer Inc. Seattle Genetics, Inc. |
None | None | 09/01/2022 |
| Sarah DeVincenzo BCPS,PharmD | None | None | None | None | 01/03/2023 |
| Mary Dwyer MS | None | None | None | None | 12/19/2022 |
| Anthony Elias MD | Astellas Pharma US, Inc. BioAtla C4 Therapeutics Epizyme Fosun Orinove ImmuneOnco Biopharmaceuticals Infinity Pharmaceuticals, Inc PTC Therapeutics QuantumLeap Health Care Collaborative Zenshine |
None | None | None | 01/06/2023 |
| Tanya Fischer MLIS,MEd | None | None | None | None | 01/03/2023 |
| Sharon Giordano MD,MPH | None | None | None | None | 02/14/2023 |
| Matthew Goetz MD | Eli Lilly and Company Pfizer Inc. Sermonix |
ARC Therapeutics AstraZeneca Pharmaceuticals LP Biotheranostics Biovica Blueprint Medicines Eagle Pharmaceuticals Eli Lilly and Company Novartis Pharmaceuticals Corporation Pfizer Inc. Sanofi Genzyme Sermonix |
Clinical Education Alliance Curio Science Medscape Research to Practice |
None | 06/14/2022 |
| Lori Goldstein MD | Daiichi- Sankyo Co. Genentech, Inc. Merck & Co., Inc. |
AstraZeneca Pharmaceuticals LP Biovica Divitum Eisai Inc. GE Health |
None | None | 06/08/2022 |
| William Gradishar MD | Daiichi- Sankyo Co. Genentech, Inc. Novartis Pharmaceuticals Corporation Seattle Genetics, Inc. |
ambrx AstraZeneca Pharmaceuticals LP Merck & Co., Inc. Pfizer Inc. |
None | None | 08/10/2022 |
| Kristina Gregory MSN,RN,OCN | None | None | None | None | 03/13/2023 |
| Evelyn Handel BCPS,PharmD,BCOP | None | None | None | None | 12/12/2022 |
| Kyle Herrmann BSN,RN,OCN | None | None | None | None | 03/06/2023 |
| Erin Hesler | None | None | None | None | 10/19/2022 |
| Sara Hurvitz MD | Alliance Foundation Trials Ambrx Arvinas AstraZeneca Pharmaceuticals LP Atossa Celcuity Cytomx Daiichi- Sankyo Co. Dantari Dignitana Eli Lilly and Company G1 Therapeutics Genentech, Inc. Gilead Sciences, Inc. GlaxoSmithKline Greenwich Life Sciences Immunomedics, Inc. Loxo Oncology Macrogenics Novartis Pharmaceuticals Corporation Orinove Orum Pfizer Inc. Phoenix Molecular Designs, Ltd. Pieris Pionyr Puma Biotechnology Quantum Leap (I-SPY Trial) Radius Roche Laboratories, Inc. Samumed sanofi-aventis U.S. Seattle Genetics, Inc. Stemline Stocks (Spouse) ROMTech, Ideal Implant Zymeworks |
4D Pharma Amgen Inc. Artios Arvinas AstraZeneca Pharmaceuticals LP Biotheranostics Biovica Catalent Biologics Catamaran Bio Cytomx Daiichi- Sankyo Co. Dantari Eli Lilly and Company Genentech, Inc. Loxo Oncology MacroGenics Medical Board of California Molecular Templates NKGen Biotech Novartis Pharmaceuticals Corporation Orum Pieris Pyxis RadioPharm Theranostics Roche Laboratories, Inc. sanofi-aventis U.S. |
None | John Wiley & Sons Publishing|Lippincott|McGraw Hill|UpToDate | 03/10/2023 |
| Rachel Jankowitz MD | None | Biotheranostics | Biotheranostics | None | 06/14/2022 |
| Sara Javid MD | None | None | None | None | 06/17/2022 |
| Jairam Krishnamurthy MD,FACP | None | None | AstraZeneca Pharmaceuticals LP Gilead Sciences, Inc. |
None | 02/11/2023 |
| Rashmi Kumar PhD | None | None | None | None | 02/05/2023 |
| A. Marilyn Leitch MD | Alliance for CLinical trials in Oncology | None | None | Alliance for CLinical Trials in Oncology | 03/13/2023 |
| Janice Lyons MD | None | None | Primum | None | 02/13/2023 |
| Meena Moran MD | None | University of Penn | None | None | 06/15/2022 |
| Joanne Mortimer MD,FACP | None | None | AstraZeneca Pharmaceuticals LP Eli Lilly and Company Incyte Corporation Novartis Pharmaceuticals Corporation Puma Biotechnology |
None | 06/06/2022 |
| Sameer Patel MD,FACS | None | None | None | None | 06/14/2022 |
| Lori Pierce MD | DSMC for big 3-07/TROG 07.01 Exact Sciences |
Breast Cancer Research Foundation Bristol-Myers Squibb Company Damon Runyon Exact Sciences |
None | ASCO|UpToDate | 08/30/2022 |
| Donna Powell CMD,DHSc,RT(T) | None | None | None | None | 12/20/2022 |
| Laura Rosenberger MD,MS | Foundation Medicine Invitae Lumicell, Inc. |
None | None | None | 12/19/2022 |
| Hope Rugo MD | AMBRX Astellas Pharma US, Inc. AstraZeneca Pharmaceuticals LP Boehringer Ingelheim GmbH Daiichi- Sankyo Co. Gilead Sciences, Inc. GlaxoSmithKline Lilly Merck & Co., Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. Pionyr Roche Laboratories, Inc. Seattle Genetics, Inc. Sermonix Taiho Pharmaceuticals Co., Ltd. Veru |
Blueprint Medicines NAPO Puma |
None | None | 12/14/2022 |
| Bryan Schneider MD | Epic Sciences Foundation Medicine Genentech, Inc. Pfizer Inc. |
None | None | None | 08/05/2022 |
| Ryan Schonfeld BA | None | None | None | None | 12/19/2022 |
| Mary Lou Smith JD,MBA | None | None | Bayer HealthCare Novartis Pharmaceuticals Corporation Pfizer Inc. |
None | 10/16/2022 |
| Hatem Soliman MD | Amgen Inc. | AstraZeneca Pharmaceuticals LP Novartis Pharmaceuticals Corporation PUMA Seattle Genetics, Inc. |
Merck & Co., Inc. | None | 01/31/2023 |
| Erica Stringer-Reasor MD | None | None | ASCO AstraZeneca Pharmaceuticals LP Eli Lilly and Company Immunomedics, Inc. Merck & Co., Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. Regeneron Pharmactcls Seattle Genetics, Inc. |
None | 01/26/2023 |
| Melinda Telli MD | AbbVie, Inc. Arvinas Bayer HealthCare G1 Therapeutics Genentech, Inc. Gilead Sciences, Inc. GlaxoSmithKline Merck & Co., Inc. OncoSec Medical Pfizer Inc. Vertex Pharmaceuticals Incorporated |
AstraZeneca Pharmaceuticals LP Blueprint Medicines Genentech, Inc. Gilead Sciences, Inc. Guardant Merck & Co., Inc. Natera Novartis Pharmaceuticals Corporation OncoSec Medical RefleXion sanofi-aventis U.S. |
None | None | 04/05/2022 |
| Mei Wei MD | None | Gilead Sciences, Inc. | Cardinal Health Onclive |
None | 10/01/2022 |
| Kari Wisinski MD | AstraZeneca Pharmaceuticals LP Context Therapeutics Daiichi- Sankyo Co. Genentech, Inc. Novartis Pharmaceuticals Corporation Pfizer Inc. Puma Biotechnology Relay Therapeutics Roche Laboratories, Inc. sanofi-aventis U.S. Seattle Genetics, Inc. Zymeworks |
Gilead Sciences, Inc. Pfizer Inc. Stemline Therapeutics |
None | None | 03/06/2023 |
| Kay Yeung PhD,MD | BioFluidica Dantari Gilead Sciences, Inc. Immunomedics, Inc. Ionis Pharmaceutical Regeneron Pharmactcls Zymeworks |
Kaneka | Elseiver | None | 10/20/2022 |
| Jessica Young MD | None | None | None | None | 12/13/2022 |